ELUT
Elutia Inc.
NASDAQ: ELUT · HEALTHCARE · MEDICAL DEVICES
$1.00
+0.00% today
Updated 2026-04-29
Market cap
$49.82M
P/E ratio
—
P/S ratio
4.05x
EPS (TTM)
$-0.64
Dividend yield
—
52W range
$1 – $3
Volume
0.1M
Elutia Inc. (ELUT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $39.04M | $42.90M | $42.68M | $47.39M | $23.85M | $24.75M | $24.38M | $12.29M |
| Revenue growth (YoY) | — | +9.9% | -0.5% | +11.0% | -49.7% | +3.8% | -1.5% | -49.6% |
| Cost of revenue | $23.09M | $23.13M | $22.12M | $28.37M | $12.21M | $13.69M | $13.67M | $5.70M |
| Gross profit | $15.95M | $19.77M | $20.56M | $19.02M | $11.64M | $11.05M | $10.71M | $6.60M |
| Gross margin | 40.8% | 46.1% | 48.2% | 40.1% | 48.8% | 44.7% | 43.9% | 53.7% |
| R&D | $2.48M | $2.40M | $5.95M | $9.27M | $7.73M | $4.40M | $3.79M | $4.16M |
| SG&A | — | $9.62M | $10.64M | $13.69M | $16.05M | $14.10M | $18.66M | $15.08M |
| Operating income | $-8.22M | $-8.41M | $-13.60M | $-23.03M | $-35.19M | $-30.53M | $-35.65M | $-18.41M |
| Operating margin | -21.1% | -19.6% | -31.9% | -48.6% | -147.5% | -123.4% | -146.3% | -149.8% |
| EBITDA | $-2.22M | $-2.67M | $-12.30M | $-15.72M | $-27.30M | $-31.92M | $-45.89M | $-17.24M |
| EBITDA margin | -5.7% | -6.2% | -28.8% | -33.2% | -114.5% | -129.0% | -188.3% | -140.2% |
| EBIT | $-6.02M | $-6.53M | $-16.17M | $-19.45M | $-31.03M | $-35.42M | $-49.34M | $-18.41M |
| Interest expense | $5.52M | $5.38M | $5.63M | $5.32M | $5.12M | $5.80M | $4.78M | $387000.00 |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-11.57M | $-11.94M | $-21.82M | $-24.83M | $-32.90M | $-37.66M | $-53.95M | $53.38M |
| Net income growth (YoY) | — | -3.2% | -82.8% | -13.8% | -32.5% | -14.5% | -43.3% | +198.9% |
| Profit margin | -29.6% | -27.8% | -51.1% | -52.4% | -137.9% | -152.2% | -221.3% | 434.2% |